A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial

sonderdruck aus: British journal of haematology | 2022

von Heß, G. | Hüttmann, A. | Witzens-Harig, M. | +13

GATA2 deficiency and MDS/AML : experimental strategies for disease modelling and future therapeutic prospects

sonderdruck aus: British journal of haematology | 2022

von Kotmayer, L. | Romero‐Moya, D. | Marin‐Bejar, O. | +6

Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice

sonderdruck aus: British journal of haematology | 2020

von Schorb, E. | Fox, C. | Kasenda, B. | +16

Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita

sonderdruck aus: British journal of haematology | 2020

von Kirschner, M. | Vieri, M. | Kricheldorf, K. | +11

Advances in understanding the pathogenesis of graft‐versus‐host disease

sonderdruck aus: British journal of haematology | 2019

von Zeiser, R.